Legend Biotech (LEGN) Shares Outstanding (2020 - 2024)

Legend Biotech (LEGN) has 5 years of Shares Outstanding data on file, last reported at $367.3 million in Q4 2024.

• In Q4 2024, Shares Outstanding rose 0.96% year-over-year to $367.3 million; the TTM figure through Dec 2024 stood at $367.3 million (up 0.96% YoY), while the FY2024 annual figure was $367.3 million, up 0.96% from the prior year.
• Shares Outstanding advanced to $367.3 million in Q4 2024, from $363.8 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $367.3 million in Q4 2024 and bottomed at $266.0 million in Q4 2020.
• A 5-year average of $327.1 million and a median of $330.1 million in 2022 frame the typical range for Shares Outstanding.
• Annual changes were most pronounced in 2021 — Shares Outstanding gained 15.96% — and 2024, when it grew 0.96%.
• Year by year, Shares Outstanding stood at $266.0 million in 2020, then increased by 15.96% to $308.5 million in 2021, then advanced by 7.03% to $330.1 million in 2022, then grew by 10.2% to $363.8 million in 2023, then grew by 0.96% to $367.3 million in 2024.
• The last three Shares Outstanding figures came in at $367.3 million (Q4 2024), $363.8 million (Q4 2023), and $330.1 million (Q4 2022), per Business Quant data.

Peer Comparison